Low birthweight in relation to placental abruption and maternal thrombophilia status

American Journal of Obstetrics and Gynecology

Volumn 198, Issue 3, 2008, Pages 293.e1-293.e5

  Nath, Carl A ^a   Ananth, Cande V ^a   DeMarco, Celeste ^a   Vintzileos, Anthony M ^a  

^a Department of Emergency Medicine   (United States)

Author keywords

fetal growth restriction; maternal thrombophilia; placental abruption; preterm birth

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5 LEIDEN; CARDIOLIPIN ANTIBODY; PROTEIN C; PROTEIN S; PROTHROMBIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; HUMAN; INTRAUTERINE GROWTH RETARDATION; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PREMATURE LABOR; PRIORITY JOURNAL; SMALL FOR DATE INFANT; SOLUTIO PLACENTAE; THROMBOPHILIA; UNITED STATES;

EID: 39649114567     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.09.011     Document Type: Article

References (25)

1. Ananth C.V., and Wilcox A.J. Placental abruption and perinatal mortality in the United States. Am J Epidemiol 153 (2001) 332-337
2. Lindqvist P.G., and Happach C. Risk and risk estimation of placental abruption. Eur J Obstet Gynecol Reprod Biol 126 (2006) 160-164
3. Kramer M.S., Usher R.H., Pollack R., Boyd M., and Usher S. Etiologic determinants of abruptio placentae. Obstet Gynecol 89 (1997) 221-226
4. Ananth C.V., Berkowitz G.S., Savitz D.A., and Lapinski R.H. Placental abruption and adverse perinatal outcomes. JAMA 282 (1999) 1646-1651
5. Goldenberg R.L., and Culhane J.F. Low birth weight in the United States. Am J Clin Nutr 85 (2007) 584S-590S
6. Naeye R.L., Harkness W.L., and Utts J. Abruptio placentae and perinatal death: a prospective study. Am J Obstet Gynecol 128 (1977) 740-746
7. Many A., Schreiber L., Rosner S., Lessing J.B., Eldor A., and Kupferminc M.J. Pathologic features of the placenta in women with severe pregnancy complications and thrombophilia. Obstet Gynecol 98 (2001) 1041-1044
8. Redline R.W., Heller D., Keating S., and Kingdom J. Placental diagnostic criteria and clinical correlation-a workshop report. Placenta 26 Suppl A (2005) S114-S117
9. Redline R.W. Thrombophilia and placental pathology. Clin Obstet Gynecol 49 (2006) 885-894
10. Yeo L., Ananth C., and Vintzileos A. Placenta abruption. In: Sciarra J. (Ed). Gynecology and obstetrics (2003), Lippincott, Williams & Wilkins, Hagerstown (MD)
11. Ananth C.V., Elsasser D.A., Kinzler W.L., et al. Polymorphisms in methionine synthase reductase and betaine-homocysteine S-methyltransferase genes: risk of placental abruption. Mol Genet Metab 91 (2007) 104-110
12. Alexander G.R., Himes J.H., Kaufman R.B., Mor J., and Kogan M. A United States national reference for fetal growth. Obstet Gynecol 87 (1996) 163-168
13. Rasmussen S., Irgens L.M., and Dalaker K. A history of placental dysfunction and risk of placental abruption. Paediatr Perinat Epidemiol 13 (1999) 9-21
14. Rasmussen S., Irgens L.M., and Dalaker K. Outcome of pregnancies subsequent to placental abruption: a risk assessment. Acta Obstet Gynecol Scand 79 (2000) 496-501
15. Kupferminc M.J., Rimon E., Ascher-Landsberg J., Lessing J.B., and Many A. Perinatal outcome in women with severe pregnancy complications and multiple thrombophilias. J Perinat Med 32 (2004) 225-227
16. Prochazka M., Happach C., Marsal K., Dahlback B., and Lindqvist P.G. Factor V Leiden in pregnancies complicated by placental abruption. Br J Obstet Gynaecol 110 (2003) 462-466
17. Gebhardt G.S., Scholtz C.L., Hillermann R., and Odendaal H.J. Combined heterozygosity for methylenetetrahydrofolate reductase (MTHFR) mutations C677T and A1298C is associated with abruptio placentae but not with intrauterine growth restriction. Eur J Obstet Gynecol Reprod Biol 97 (2001) 174-177
18. Facchinetti F., Marozio L., Grandone E., Pizzi C., Volpe A., and Benedetto C. Thrombophilic mutations are a main risk factor for placental abruption. Haematologica 88 (2003) 785-788
19. Robertson L., Wu O., Langhorne P., et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol 132 (2006) 171-196
20. Wiener-Megnagi Z., Ben-Shlomo I., Goldberg Y., and Shalev E. Resistance to activated protein C and the Leiden mutation: high prevalence in patients with abruptio placentae. Am J Obstet Gynecol 179 (1998) 1565-1567
21. Espinoza J., Romero R., Mee Kim Y., et al. Normal and abnormal transformation of the spiral arteries during pregnancy. J Perinat Med 34 (2006) 447-458
22. Levine R.J., Maynard S.E., Qian C., et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350 (2004) 672-683
23. Levine R.J., Lam C., Qian C., et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355 (2006) 992-1005
24. Signore C., Mills J.L., Qian C., et al. Circulating angiogenic factors and placental abruption. Obstet Gynecol 108 (2006) 338-344
25. Zhang X.Q., Craven C., Nelson L., Varner M.W., and Ward K.J. Placental abruption is more frequent in women with the angiotensinogen Thr235 mutation. Placenta 28 (2007) 616-619